AstraZeneca Prepares For U.S. Statin Market Shake-Up As Lipitor Goes Generic
This article was originally published in The Pink Sheet Daily
Executive Summary
Pricing pressure on AstraZeneca's Crestor expected from the arrival of generic atorvastatin in the U.S. in the fourth quarter.